TERRACCIANO, Stefania
 Distribuzione geografica
Continente #
AS - Asia 7.668
NA - Nord America 4.479
EU - Europa 1.663
SA - Sud America 334
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 36
OC - Oceania 3
Totale 14.339
Nazione #
HK - Hong Kong 6.057
US - Stati Uniti d'America 4.336
IT - Italia 731
SG - Singapore 696
CN - Cina 391
BR - Brasile 247
VN - Vietnam 191
RU - Federazione Russa 189
DE - Germania 185
UA - Ucraina 145
CA - Canada 80
TR - Turchia 68
FR - Francia 64
IE - Irlanda 64
SE - Svezia 61
GB - Regno Unito 60
IN - India 57
FI - Finlandia 52
KR - Corea 40
BD - Bangladesh 30
MX - Messico 30
AR - Argentina 29
JP - Giappone 29
NL - Olanda 21
PL - Polonia 21
CO - Colombia 14
ID - Indonesia 14
AT - Austria 13
CZ - Repubblica Ceca 13
ES - Italia 13
EC - Ecuador 12
IQ - Iraq 12
PH - Filippine 12
ZA - Sudafrica 12
PK - Pakistan 10
CL - Cile 9
UZ - Uzbekistan 9
VE - Venezuela 9
AZ - Azerbaigian 8
HU - Ungheria 6
MA - Marocco 6
SA - Arabia Saudita 6
CH - Svizzera 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
MY - Malesia 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
PE - Perù 4
PR - Porto Rico 4
RO - Romania 4
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
SC - Seychelles 1
Totale 14.182
Città #
Hong Kong 6.040
Ann Arbor 579
San Jose 450
Singapore 409
Dallas 332
Chandler 306
Ashburn 251
Woodbridge 236
Milan 214
Jacksonville 174
Wilmington 170
Princeton 166
Houston 160
Council Bluffs 133
Salerno 103
Beijing 95
The Dalles 79
New York 72
Dublin 62
Los Angeles 59
Munich 59
Lauterbourg 55
Izmir 53
Ho Chi Minh City 52
Naples 52
Rome 50
Nanjing 46
Hanoi 44
Santa Clara 38
Montreal 36
Andover 35
Orem 31
Boardman 30
Dearborn 29
Tokyo 29
Pellezzano 28
Phoenix 25
São Paulo 25
Memphis 24
Moscow 24
Turku 24
Fisciano 23
Brooklyn 20
Frankfurt am Main 20
Stockholm 19
Warsaw 19
Chengdu 17
Redwood City 17
Boston 16
Guangzhou 16
Atlanta 15
Chennai 15
Columbus 15
Denver 15
Fairfield 15
Figino 15
Nuremberg 15
Turin 14
Chicago 13
Mexico City 13
Da Nang 12
Dong Ket 12
Jiaxing 12
London 12
Changsha 11
Hebei 11
Brno 10
Johannesburg 10
San Francisco 10
Washington 10
Amsterdam 9
Belo Horizonte 9
Charlotte 9
Nanchang 9
Norwalk 9
Seattle 9
Shenyang 9
Toronto 9
Düsseldorf 8
Hải Dương 8
Manchester 8
Mestre 8
New Delhi 8
Newark 8
Philadelphia 8
Baku 7
Ottawa 7
Pune 7
Ankara 6
Curitiba 6
Dhaka 6
San Diego 6
Tashkent 6
Baghdad 5
Biên Hòa 5
Caianello 5
Campinas 5
Catania 5
Chandigarh 5
Falls Church 5
Totale 11.515
Nome #
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 1.141
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 964
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 650
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 631
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 618
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 564
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 552
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 538
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 410
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 378
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 272
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 224
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 224
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 217
Structural basis for the design and synthesis of selective HDAC inhibitors 200
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 200
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 197
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 197
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 196
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 183
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 179
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 176
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 173
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 173
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 172
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 172
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 171
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 171
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 168
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 161
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 157
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 155
Discovery of new potent molecular entities able to inhibit mPGES-1 151
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 149
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 145
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 144
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 144
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 141
Conformationally locked calixarene-based histone deacetylase inhibitors 141
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 140
Hsp90 Activity Modulation by Plant Secondary Metabolites 137
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 135
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 135
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 133
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 133
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 127
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 126
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 125
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 125
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 124
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 112
Discovery of noscapine derivatives as potential β-tubulin inhibitors 112
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 112
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 104
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 104
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 103
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 96
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 91
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 81
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 80
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 61
Disruption of c-Myc/Max heterodimerization induced by a novel anticancer agent endowed with 1,3-diphenylurea moiety: an in silico, chemoproteomics-based, and in vitro combined approach 40
A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1 36
Unveiling New Triazoloquinoxaline‐Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9 35
Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways 33
The future of BRD9 inhibitors: a patent perspective (2019-present) 27
From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies 25
Carnosol modulates mPGES-1/PPAR-γ biological axis: from in silico to in vivo clinical imaging and investigations 23
Advancing Non-Small-Cell Lung Cancer Management Through Multi-Omics Integration: Insights from Genomics, Metabolomics, and Radiomics 15
Discovery of New Antioxidant Molecules Enhancing the Nrf2-Mediated Pathway: Docking Studies and Biological Evaluation 10
Totale 14.339
Categoria #
all - tutte 36.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 0 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025951 30 7 6 43 28 80 230 65 129 47 123 163
2025/20269.297 1.665 2.574 2.414 314 422 200 446 108 242 417 123 372
2026/2027694 111 117 269 197 0 0 0 0 0 0 0 0
Totale 14.339